"Vasoconstrictor Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause constriction of the blood vessels.
Descriptor ID |
D014662
|
MeSH Number(s) |
D27.505.954.411.793
|
Concept/Terms |
Vasoconstrictor Agents- Vasoconstrictor Agents
- Agents, Vasoconstrictor
- Vasoconstrictor Drugs
- Drugs, Vasoconstrictor
- Vasoconstrictors
- Vasoactive Agonists
- Agonists, Vasoactive
- Vasopressor Agents
- Agents, Vasopressor
|
Below are MeSH descriptors whose meaning is more general than "Vasoconstrictor Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasoconstrictor Agents".
This graph shows the total number of publications written about "Vasoconstrictor Agents" by people in this website by year, and whether "Vasoconstrictor Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 3 | 0 | 3 |
1998 | 1 | 2 | 3 |
1999 | 1 | 2 | 3 |
2003 | 0 | 1 | 1 |
2004 | 4 | 3 | 7 |
2005 | 4 | 2 | 6 |
2006 | 2 | 3 | 5 |
2007 | 1 | 3 | 4 |
2008 | 1 | 2 | 3 |
2009 | 0 | 3 | 3 |
2010 | 3 | 5 | 8 |
2011 | 1 | 2 | 3 |
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2014 | 2 | 3 | 5 |
2015 | 3 | 0 | 3 |
2016 | 2 | 3 | 5 |
2017 | 1 | 2 | 3 |
2018 | 3 | 2 | 5 |
2019 | 4 | 3 | 7 |
2020 | 4 | 6 | 10 |
2021 | 0 | 3 | 3 |
2022 | 0 | 3 | 3 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vasoconstrictor Agents" by people in Profiles.
-
Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery. Crit Care Clin. 2024 Jan; 40(1):73-88.
-
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther. 2022 10; 56(8):1284-1293.
-
Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial. JAMA. 2022 07 19; 328(3):270-279.
-
Evaluation of the Addition of Angiotensin II in Patients With Shock After Cardiac Surgery at a Veterans Affairs Medical Center. Ann Pharmacother. 2023 02; 57(2):141-147.
-
Administration of vasopressors through peripheral venous catheters. CMAJ. 2022 05 30; 194(21):E739.
-
Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution. Kidney Int. 2021 06; 99(6):1321-1330.
-
Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry. Crit Care Med. 2021 03 01; 49(3):437-448.
-
Shock Severity and Hospital Mortality In Out of Hospital Cardiac Arrest Patients Treated With Targeted Temperature Management. Shock. 2021 01 01; 55(1):48-54.
-
Intraoperative Management of Carotid Endarterectomy in Patients With Left Ventricular Assist Devices-The Challenge of Continuous Flow: A Case Report. A A Pract. 2020 Dec; 14(14):e01355.
-
Effects of Vasopressin Infusion After Pediatric Cardiac Surgery: A Meta-analysis. Pediatr Cardiol. 2021 Feb; 42(2):225-233.